Abbott (ABT) Reports In-Line Q1 EPS; offers guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $114.10 -1.75%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q1 EPS of $1.15, in-line with the analyst estimate of $1.15. Revenue for the quarter came in at $11.16 billion versus the consensus estimate of $11 billion.
GUIDANCE:
Abbott sees Q2 2026 EPS of $1.25-$1.31, versus the consensus of $1.32.
Abbott sees FY2026 EPS of $5.38-$5.58, versus the consensus of $5.47.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tenable Holdings, Inc. (TENB) to Join S&P SmallCap 600
- JPMorgan Starts Toho Co Ltd. (9602:JP) (TKCOF) at Overweight
- Lantronix (LTRX) Reports In-Line Q4 EPS; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
